FDA approves Novavax’s updated COVID vaccine targeting JN.1 strain
The U.S. Food and Drug Administration on Friday granted emergency approval for an updated version of the Novavax COVID vaccine. The updated vaccine is authorised for use in individuals 12 years of age and older and will target the JN.1 strain of the virus.
ПОПУЛЯРНЫЕ ПОСТЫ
Bluetongue outbreak in a Portuguese sheep farm has broken out
Сентябрь 19, 2024
Austria says disaster fund to rise to 1 billion euros
Сентябрь 19, 2024
Portugal gets help from Spain and Morocco in response to fires
Сентябрь 19, 2024
Drought reduces Amazon rivers to historic lows
Сентябрь 19, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ